Literature DB >> 17135655

Standard of care for gastric cancer based on meta-analysis? Treading on thin ice or it is very nice!

Jaffer A Ajani.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17135655     DOI： 10.1200/JCO.2006.08.2289

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Implementation and limitations of meta-analysis of randomized trials from the clinical biostatistician's point of view.

Authors:  Junichi Sakamoto
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

2.  Chemotherapy for advanced gastric cancer: a new milestone lies ahead.

Authors:  Hiroya Takiuchi
Journal:  Gastrointest Cancer Res       Date:  2007-09

3.  Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.

Authors:  Xiaodong Zhu; Xiaoying Zhao; Wei Peng; Si Sun; Jun Cao; Dongmei Ji; Xin Liu; Chenchen Wang; Mingzu Huang; Hui Yu; Weijian Guo; Jin Li; Jiliang Yin
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-18       Impact factor: 4.553

4.  Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.

Authors:  Xin-Zu Chen; Kun Jiang; Jian-Kun Hu; Bo Zhang; Hong-Feng Gou; Kun Yang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.